Shawn E Fellows
Overview
Explore the profile of Shawn E Fellows including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
37
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fellows S, Maciulewicz T, Conn K, Patel V
Curr Pharm Teach Learn
. 2023 Mar;
15(1):57-61.
PMID: 36898887
Introduction: Simulation in healthcare has been a widely adopted modality to gain practical experience prior to working directly with patients. While simulation in academic settings affords many opportunities to enhance...
2.
Juba K, Van Manen R, Fellows S
Ann Pharmacother
. 2019 Oct;
54(3):247-253.
PMID: 31648533
Hypoglycemia is a rare adverse effect of tramadol that is described in the medical literature and package insert. The purpose of this study was to review reports of tramadol and...
3.
Fellows S, Cipriano G
P R Health Sci J
. 2019 Sep;
38(3):189-191.
PMID: 31536634
Objective: The aim of this study was to identify potential disparities between point-of-care testing (POCT) and laboratory hemoglobin A1c (HbA1c) reporting at a Federally Qualified Health Center (FQHC). Methods: The...
4.
Polito N, Fellows S
J Emerg Med
. 2017 Oct;
53(4):540-549.
PMID: 29079070
Background: Chlorpromazine is the only drug approved by the US Food and Drug Administration for the treatment of hiccups; however, many other pharmacologic treatments have been proposed for intractable and...
5.
Fellows S, Coppola A, Gandhi M
J Opioid Manag
. 2017 Sep;
13(4):253-260.
PMID: 28953317
The effectiveness and safety of naloxone for the reversal of opioid toxicity are reviewed. A literature search was performed using PubMed, the Cochrane Library, CINAHL, and Medline. Clinical trials comparing...
6.
Rosini J, Rajasimhan S, Fellows S, Nomura J
Am J Emerg Med
. 2015 Feb;
33(7):987.e1-3.
PMID: 25669873
A 51-year-old woman with relapsing-remitting multiple sclerosis was initiated on fingolimod. She developed a Mobitz Type I (Wenckebach)second-degree atrioventricular (AV) heart block during the initial 6-hour monitoring. She was transferred...
7.
Fellows S, Rosini J, Curtis J, Volz E
J Emerg Med
. 2012 May;
44(2):e221-5.
PMID: 22595629
Background: Dabigatran etexilate is the first oral direct thrombin inhibitor approved in the United States. Unlike warfarin, dabigatran has no known antidote. Providers should be aware of patients that may...